{"nctId":"NCT00131248","briefTitle":"Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants","startDateStruct":{"date":"2004-04"},"conditions":["Gastroesophageal Reflux"],"count":18,"armGroups":[{"label":"Anti-reflux Medications, then Placebo (group 1)","type":"OTHER","interventionNames":["Drug: Metaclopramide","Drug: Ranitidine","Drug: placebo"]},{"label":"Placebo, then Anti-reflux Medications","type":"OTHER","interventionNames":["Drug: Metaclopramide","Drug: Ranitidine","Drug: placebo"]}],"interventions":[{"name":"Metaclopramide","otherNames":[]},{"name":"Ranitidine","otherNames":[]},{"name":"placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Premature infants \\< 37 weeks gestation at birth; currently less than 44 weeks postmenstrual age.\n* Not currently receiving mechanical ventilation\n* Clinical diagnosis of GER and apnea/bradycardia suspected by the clinicians to be related to the GER. (Supporting diagnostic test information, such as upper gastrointestinal series \\[UGI\\] studies and pH probes will be recorded but not required for study enrollment.)\n* Attending physician plan to begin anti-reflux medications\n* Infants may be included in the study if they are on continuous positive airway pressure (CPAP) or methylxanthines for treatment of apnea only if the clinicians are willing to maintain the same regimen for the two-week duration of the study.\n* Stable feeding regimen\n\nExclusion Criteria:\n\n* History of congenital neurological defect\n* Imminent discharge (within 2 weeks)\n* Parent refusal","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Month","maximumAge":"6 Months","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Bradycardia Episodes/Day","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.6","spread":"3.1"},{"groupId":"OG001","value":"3.6","spread":"2.7"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":17},"commonTop":[]}}}